And reputational cost. We wonder why the ASX doesn't rate us as...

And reputational cost. We wonder why the ASX doesn't rate us as we think it should and broking firms won't research us - it's because of our history of not delivering. I thought we were past that with new management.

Shareholders were told at the last quarterly update April for first dosing. Then we were copied on a presentation to be delivered in the USA that May was first dosing. Now we hear via a discussion with a members only investment media company that it's first patient enrolled in May - not dosed. I get it that there are lots of variables at play but please talk to us - don't continue with movable deadlines with no discussion.